ABSTRACT-Mouse L-929 cells were treated with benzo[a)pyrene [(BP) CAS: 50-32-8) for 24 hours. Several cultures of cells were immediately treated with polyriboinosinic-polyribocytidylic acid (poly I:C) to induce interferon-alpha/beta (IFN). Other sets of cultures were washed and allowed to incubate with fresh culture medium for 3-18 hours before addition of poly I:C to induce IFN. The IFN induction was severely inhibited in cells treated with BP and immediately challenged with poly I:C as compared to non-BP-treated cells. Up to a 6-hour delay in addition of poly I:C still resulted in severe inhibition of IFN induction; however, a delay of 9 hours or longer allowed the cells to recover their IFN production capacity. These data indicate that the inhibition of IFN induction by BP was reversible. The number of cells laid down in the cultures was approximately 6X10
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. In another experiment, the number of cells laid down in culture was serially decreased in several different cultures. These normal cells were then treated with poly I:C to induce IFN. A 50% decrease in the number of cells was required to reduce IFN production by 50%. In BP-treated L-929 cells, viabilities ranged from 88 to 90%, but IFN induction was inhibited by greater than 50%. These results suggest that toxicity of carcinogens to cells does not play a major role in inhibition of IFN induction by carcinogens.-JNCI 1984; 73:763-766.
The production of IFN has been shown to be inhibited by pretreatment of cell cultures with carcinogens (1-6). IFN production by cells treated with poorly carcinogenic or noncarcinogenic analogues had little or no effect on production of IFN.
Although previous studies suggested that inhibition of IFN induction by carcinogens was not due to the direct toxic effects of the carcinogens on the cell cultures, this point has remained in dispute (1) (2) (3) (4) (5) (6) . Normal or enhanced virus replication in carcinogentreated cells and lack of staining of these cells in trypan blue viability assays have been cited as evidence for the viability of those cells (1) (2) (3) (4) (5) (6) .
The present study was performed to address further the issue of viability of carcinogen-treated cultures induced to produce IFN. Manipulations in exposure conditions of L-929 cells to BP have been used to demonstrate that mechanisms other than direct toxicity to cell cultures probably play a major role in the inhibition of IFN induction by carcinogens. IFN induction.-Mouse IFN was induced in L-929 cells as described previously (7) . Poly I:C (50 /-Lg) was added to each culture for 45-60 minutes. DEAEdextran (100 /-Lg) was included to ensure maximum induction of IFN (7) . After incubation, sufficient MEM was added to each culture to bring it to a final volume of 2 ml. The cultures were incubated for 24 hours at 37°C in 5% C02, and then culture supernatants were harvested and assayed for antivirus activity.
MATERIALS AND METHODS

Cell
IFN assay.-IFN antivirus activity was determined by means of a microplaque reduction assay with the use of L-929 cells and the Indiana strain of vesicular stomatitis virus (8) . The IFN titer corresponded to the reciprocal of the greatest dilution of test sample that inhibited virus plaques by 50%. One IFN antivirus unit was equivalent to 0.88 National Institutes of Health G-002-904-511 reference units in this assay.
Statistical analysis.-Data were analyzed by means of a two-tailed Student's t-test with the P-value set a priori at 0.01 or less. 
RESULTS
Effect of chemical treatment on viability of L-
• was added to the cultures 24 hours after addition of carcinogen (4) . Culture supernatants were assayed as described below for IFN production 24 hours after addition of carcinogen. All carcinogens were dissolved in DMSO. All treated cell cultures, as well as untreated control cultures, had from 88 to 90% viable cells as determined by trypan blue dye staining, indicating no obvious gross differences in viabilities of treated cells as compared to those of controls. This was true for all experiments described below. poly I:C was added to these cultures to determine if cultures had recovered from BP treatment. Twenty-four hours after IFN induction, culture supernatants were harvested and assayed for antivirus activity. When IFN was induced up to 6 hours after removal of BP, there was a significant decrease in inhibition of IFN induction in BP-treated cells as compared to that in controls (text- fig. I ). A 9-hour or longer delay in induction of IFN after BP treatment resulted in no significant inhibition of IFN induction (text-fig. I ). Treatment of cells with DMSO only, the solvent for carcinogens, never inhibited IFN induction (data not shown).
Reversibility of inhibition of IFN induction by
Relationship of cell number to IFN production.-To determine if a loss in cell viability due to toxicity of BP to L-929 cells could account for inhibition of IFN induction by BP, we allowed various numbers of L-929 cells to attach to tissue culture plates for 2 hours and then induced IFN with poly I:C. Twenty-four hours later, culture supernatants were harvested and assayed for IFN antivirus activity. At densities of 6XI0 4 to 6XI0 
DISCUSSION
Pretreatment of cell cultures with carcinogens has been shown to inhibit IFN induction (1) (2) (3) (4) (5) (6) 9) . Since the IFN assay was a biologic assay and a titration, a twofold change (50% decrease or 100% increase) in IFN titer was required for a treatment to be considered effective (4) . Statistical significance also was required (4). Poorly carcinogenic or noncarcinogenic analogues 
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had no effect on IFN induction (1) (2) (3) (4) (5) (6) 9) . Toxicity of the carcinogens for the cell cultures was not believed to play a major role in inhibition of IFN induction because of trypan blue viability staining (4) (5) (6) and normal virus replication in carcinogen-treated cells (2); however, some contribution of toxic effects of carcinogens could not be ruled out. The results of the present experiments indicate that BP-treated cells that had inhibited IFN induction could recover with time after BP was removed. Cells treated in such a fashion recovered their full ability to produce IFN. The presence of 10% FBS in the incubation medium did not accelerate the recovery of the IFN production capacity. The rapid reversibility of inhibition of IFN induction suggests that the critical interaction between BP and cell components is one of low affinity. This could suggest a translational block rather than a transcriptional block. Further studies with other inducible proteins are in progress and could clarify whether this type of inhibition of induction by BP is specific to IFN.
Additional studies indicated that decreases in cell numbers of 50% were required to reduce IFN induction by 50%. When cell cultures were treated with BP, the number of viable cells as determined by trypan blue viability staining was not significantly different from control cells, yet IFN production was decreased by more than 50% in BP-treated cells. Although toxic effects of BP could occur that were undetectable by trypan blue staining, these results suggest that interactions of BP with cell cultures other than direct cytotoxicity are required for IFN induction to be inhibited.
L-929 cells were treated with doses of BP or DMBA below the critical concentration required to inhibit IFN induction. This treatment blocked the inhibition of IFN induction in those cells by later application of high doses of BP or DMBA. Blockage of the inhibition of IFN induction by BP has been previously reported when cells were pretreated with noncarcinogenic analogues (10) . These results parallel those observed in induction of tumors with polycyclic aromatic hydrocarbon carcinogens. Treatment of mice with polycyclic aromatic hydrocarbons, both carcinogenic and noncarcinogenic, can delay or inhibit tumor development in mice exposed to DMBA. This phenomenon may be due to competition for metabolizing enzymes or to competition for DNA or protein-binding sites (11) . These possibilities also exist for the results of the present study.
Addition of several low doses of BP to cells prior to induction of IFN did not result in inhibition of IFN induction. These results suggest that a threshold dose, and not a cumulative effect, was required for BP to inhibit IFN induction.
